Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 2 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial.
Lancet. 2020 Jan 4;395(10217):53-64. doi: 10.1016/S0140-6736(19)32971-X. Epub 2019 Dec 5.
Lancet. 2020.
PMID: 31813637
Clinical Trial.
Challenges and opportunities for quality densitometry in Latin America.
Maeda SS, LLibre RDS, Arantes HP, de Souza GC, Molina FFC, Wiluzanski D, Taborda JAC, Montaño CC, Vargas TM, Lopez GLF, Neira LV, Uribe GAM, Salica D, Bencosme AR, Perez SC, Acosta CRR, Carey JJ, Borges JLC.
Maeda SS, et al. Among authors: molina ffc.
Arch Osteoporos. 2021 Feb 2;16(1):23. doi: 10.1007/s11657-021-00892-y.
Arch Osteoporos. 2021.
PMID: 33528678
Review.
Item in Clipboard
Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial.
Park W, Božić-Majstorović L, Milakovic D, Berrocal Kasay A, El-Khouri EC, Irazoque-Palazuelos F, Molina FFC, Shesternya P, Miranda P, Medina-Rodriguez FG, Wiland P, Jeka S, Chavez-Corrales J, Garmish O, Linde T, Rekalov D, Hrycaj P, Krause A, Fomina N, Piura O, Abello-Banfi M, Suh CH, Shim SC, Lee SJ, Lee SY, Kim SH, Yoo DH.
Park W, et al. Among authors: molina ffc.
MAbs. 2018 Aug/Sep;10(6):934-943. doi: 10.1080/19420862.2018.1487912. Epub 2018 Jul 16.
MAbs. 2018.
PMID: 30010481
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled Trial.
Yoo DH, Suh CH, Shim SC, Jeka S, Molina FFC, Hrycaj P, Wiland P, Lee EY, Medina-Rodriguez FG, Shesternya P, Radominski S, Stanislav M, Kovalenko V, Sheen DH, Myasoutova L, Lim MJ, Choe JY, Lee SJ, Lee SY, Kim SH, Park W.
Yoo DH, et al. Among authors: molina ffc.
BioDrugs. 2017 Aug;31(4):357-367. doi: 10.1007/s40259-017-0232-7.
BioDrugs. 2017.
PMID: 28612179
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis.
Park W, Suh CH, Shim SC, Molina FFC, Jeka S, Medina-Rodriguez FG, Hrycaj P, Wiland P, Lee EY, Shesternya P, Kovalenko V, Myasoutova L, Stanislav M, Radominski S, Lim MJ, Choe JY, Lee SJ, Lee SY, Kim SH, Yoo DH.
Park W, et al. Among authors: molina ffc.
BioDrugs. 2017 Aug;31(4):369-377. doi: 10.1007/s40259-017-0233-6.
BioDrugs. 2017.
PMID: 28600696
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite